Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), Corbus Pharmaceuticals (CRBP) and Fortrea Holdings Inc. (FTRE)

TipRanksDec 17 18:30 · Ratings

Promising Potential of Corbus Pharmaceuticals: Buy Rating Reinforced by Key Assets and Strategic Focus

TipRanksDec 12 15:15 · Ratings

Express News | Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-in-Human Study of Crb-601 to Treat Patients With Advanced Solid Tumors

BreakingsDec 9 20:00

Corbus Pharmaceuticals Announces Dosing of First Patient in Its First-In-Human Study of CRB-601 to Treat Patients With Advanced Solid Tumors

Corbus PharmaceuticalsDec 9 13:00

Corbus Pharmaceuticals Receives Fast Track From FDA for Cervical Cancer Treatment

WSJDec 3 20:20

Express News | Corbus Pharmaceuticals Holdings Inc - First Data From Dose Escalation Study Expected in Q1 2025

BreakingsDec 3 20:04